Literature DB >> 15596614

APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.

Wenyong Huang1, Chengxuan Qiu, Eva von Strauss, Bengt Winblad, Laura Fratiglioni.   

Abstract

BACKGROUND: Both family aggregation and apolipoprotein E (APOE) epsilon4 allele are well-known risk factors for dementia, but the relation between these two factors remains unclear.
OBJECTIVE: To explore whether the risk of dementia and Alzheimer disease (AD) due to a positive family history is explained by APOE genotypes.
DESIGN: Community-based cohort study.
SETTING: The Kungsholmen district of Stockholm, Sweden. PARTICIPANTS: A total of 907 nondemented people 75 years or older, followed up for 6 years to detect incident dementia and AD cases according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. MAIN OUTCOME MEASURES: Risk of dementia and AD by Cox proportional hazards models after controlling for several potential confounders.
RESULTS: Subjects who had at least 2 siblings with dementia were at an increased risk of AD. Individuals with both APOE epsilon4 allele and at least 2 affected first-degree relatives had a higher risk of dementia and AD compared with those without these 2 factors. Similar results were obtained for history of dementia separately in parents or siblings. Among the epsilon4 allele carriers, subjects with 2 or more first-degree demented relatives had increased risk of dementia and AD, whereas no increased risk was detected among non-epsilon4 carriers.
CONCLUSIONS: Family history of dementia was associated with an increased risk of dementia and AD in this very old population, but only among APOE epsilon4 carriers. This suggests the existence of other genetic or environmental risk factors that may be active in the presence of the APOE epsilon4 allele.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15596614     DOI: 10.1001/archneur.61.12.1930

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  41 in total

1.  Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons.

Authors:  David J Moore; Miguel Arce; Suzanne Moseley; J Allen McCutchan; Jennifer Marquie-Beck; Donald R Franklin; Florin Vaida; Cristian L Achim; Justin McArthur; Susan Morgello; David M Simpson; Benjamin B Gelman; Ann C Collier; Christina M Marra; David B Clifford; Robert K Heaton; Igor Grant
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2011       Impact factor: 2.198

2.  Thickness of the human cerebral cortex is associated with metrics of cerebrovascular health in a normative sample of community dwelling older adults.

Authors:  Elizabeth C Leritz; David H Salat; Victoria J Williams; David M Schnyer; James L Rudolph; Lewis Lipsitz; Bruce Fischl; Regina E McGlinchey; William P Milberg
Journal:  Neuroimage       Date:  2010-10-28       Impact factor: 6.556

3.  Association between white matter microstructure, executive functions, and processing speed in older adults: the impact of vascular health.

Authors:  Heidi I L Jacobs; Elizabeth C Leritz; Victoria J Williams; Martin P J Van Boxtel; Wim van der Elst; Jelle Jolles; Frans R J Verhey; Regina E McGlinchey; William P Milberg; David H Salat
Journal:  Hum Brain Mapp       Date:  2011-09-23       Impact factor: 5.038

4.  Interactive effects of apolipoprotein E4 and diabetes risk on later myelinating white matter regions in neurologically healthy older aged adults.

Authors:  Jessica M Foley; David H Salat; Nikki H Stricker; Tyler A Zink; Laura J Grande; Regina E McGlinchey; William P Milberg; Elizabeth C Leritz
Journal:  Am J Alzheimers Dis Other Demen       Date:  2013-12-31       Impact factor: 2.035

5.  Glucose Dysregulation Interacts With APOE-∊4 to Potentiate Temporoparietal Cortical Thinning.

Authors:  Jessica M Foley; David H Salat; Nikki H Stricker; Regina E McGlinchey; William P Milberg; Laura J Grande; Elizabeth C Leritz
Journal:  Am J Alzheimers Dis Other Demen       Date:  2015-05-24       Impact factor: 2.035

6.  Association of parental dementia with cognitive and brain MRI measures in middle-aged adults.

Authors:  S Debette; P A Wolf; A Beiser; R Au; J J Himali; A Pikula; S Auerbach; C Decarli; S Seshadri
Journal:  Neurology       Date:  2009-12-09       Impact factor: 9.910

Review 7.  Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.

Authors:  Christina E Wierenga; Mark W Bondi
Journal:  Neuropsychol Rev       Date:  2007-05-03       Impact factor: 7.444

8.  Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study.

Authors:  Kathleen M Hayden; Peter P Zandi; Nancy A West; Joann T Tschanz; Maria C Norton; Chris Corcoran; John C S Breitner; Kathleen A Welsh-Bohmer
Journal:  Arch Neurol       Date:  2009-11

9.  Hippocampal infusions of apolipoprotein E peptides induce long-lasting cognitive impairment.

Authors:  Donnie Eddins; Rebecca C Klein; Jerrel L Yakel; Edward D Levin
Journal:  Brain Res Bull       Date:  2009-01-29       Impact factor: 4.077

10.  Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities.

Authors:  Adam C Naj; Gary W Beecham; Eden R Martin; Paul J Gallins; Eric H Powell; Ioanna Konidari; Patrice L Whitehead; Guiqing Cai; Vahram Haroutunian; William K Scott; Jeffery M Vance; Michael A Slifer; Harry E Gwirtsman; John R Gilbert; Jonathan L Haines; Joseph D Buxbaum; Margaret A Pericak-Vance
Journal:  PLoS Genet       Date:  2010-09-23       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.